Erythropoietin in Critical Illness and Trauma
- PMID: 30784609
- DOI: 10.1016/j.ccc.2018.11.015
Erythropoietin in Critical Illness and Trauma
Abstract
Erythropoietin (EPO) is a 34kD pleiotropic cytokine that was first identified as being essential for red blood cell (RBC) production. It is now recognized however that EPO is produced by many tissues. It plays a key role in the modulation of the response to injury, inflammation, and tissue hypoxia via the inhibition of apoptosis. Large clinical trials in the critically ill failed to demonstrate a role for EPO as an RBC transfusion sparing agent; however, improved clinical outcomes, attributable to EPO role in tissue protection are observed in critically ill trauma patients. Further research to confirm or refute these observations is required.
Keywords: Critical illness; Erythropoietin; Red blood cell transfusion; Trauma.
Crown Copyright © 2018. Published by Elsevier Inc. All rights reserved.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials